Company

Perspectum Diagnostics Ltd

Oxford-based imaging company whose CoverScan multi-organ MRI technology extracts biomarkers for healthcare providers.

About

Founded in 2012 in Oxford, UK, Perspectum Diagnostics Ltd develops imaging technology and is led by CEO Rajarshi Banerjee. Its CoverScan multi-organ MRI technology extracts biomarkers for liver disease, cancer and diabetes. In February 2023 the company raised USD 19 mn in Series C funding led by Oppenheimer, as part of a USD 55 mn round. For fiscal 2023 it reported revenue of USD 23,837,343.60.

1Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in